BioCryst Pharmaceuticals
$7.77
24H
Market Cap
Volume
Supply
Price Chart
About BioCryst Pharmaceuticals - BCRX
BioCryst Pharmaceuticals, Inc. is a biotechnology company that focuses on developing oral treatments for rare diseases driven by abnormal crystal formation in the body and targets conditions that involve plasma kallikrein, complement, and other biological pathways.
What are BioCryst Pharmaceuticals's core values and mission statement?
BioCryst Pharmaceuticals, Inc.'s mission statement is to discover, develop and commercialize oral treatments for patients with rare and serious diseases. Their core values focus on innovation, passion for their work, and commitment to patients, emphasizing a collaborative and results-driven work environment.
Who founded BioCryst Pharmaceuticals and when?
BioCryst Pharmaceuticals, Inc. was founded in 1986 by Charles E. Bugg.
Who leads BioCryst Pharmaceuticals?
As of the last update, the CEO of BioCryst Pharmaceuticals, Inc. is Jon Stonehouse.
Where is BioCryst Pharmaceuticals located, and what is its base country?
BioCryst Pharmaceuticals, Inc. is headquartered in Durham, North Carolina, USA, and its base country is the United States.
On which exchanges is BioCryst Pharmaceuticals traded?
BioCryst Pharmaceuticals, Inc. is traded on the NASDAQ stock exchange under the ticker symbol BCRX.
Historical data
BioCryst Pharmaceuticals (BCRX) Price Live Data
The live price of BioCryst Pharmaceuticals (BCRX) is $7.77, with a trading volume of 1,113,402 in the last 24 hours. Wrapstocks updates the BCRX price in real-time. BioCryst Pharmaceuticals is up 1.3% in the last 24 hours. The company has a live market cap of $1,609,402,624.00 and a supply of 207,132,991 BCRX stocks.
BioCryst Pharmaceuticals (BCRX) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 1 hour and 41 minutes.
